Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
CALL
Global X Silver Miners ETF NEW
SIL
$4.75B
| $5.9M | ﹤0.01% |
+70,600
| New | +$5.21M |
|
|
2077
PUT
Global X Silver Miners ETF NEW
SIL
$4.75B
| $5.9M | ﹤0.01% |
+70,600
| New | +$5.21M |
|
2078
Genworth Financial
GNW
$3.77B
| $5.89M | ﹤0.01% |
652,766
+43,346
| +7% | +$377K |
|
2079
AXIS Capital
AXS
$7.3B
| $5.89M | ﹤0.01% |
55,039
+14,559
| +36% | +$1.45M |
|
2080
National Health Investors
NHI
$3.5B
| $5.88M | ﹤0.01% |
76,996
+10,060
| +15% | +$771K |
|
2081
Oric Pharmaceuticals
ORIC
$1.42B
| $5.88M | ﹤0.01% |
718,535
+534,444
| +290% | +$6.15M |
|
2082
Haleon
HLN
$43.2B
| $5.87M | ﹤0.01% |
580,657
+310,657
| +115% | +$2.95M |
|
2083
CALL
Lucid Motors
LCID
$2.54B
| $5.87M | ﹤0.01% |
555,000
+109,840
| +25% | +$1.76M |
|
2084
Newell Brands
NWL
$2.63B
| $5.87M | ﹤0.01% |
1,576,683
-659,319
| -29% | -$2.66M |
|
2085
Valmont Industries
VMI
$9.5B
| $5.86M | ﹤0.01% |
14,576
-9,193
| -39% | -$3.74M |
|
2086
Trex
TREX
$5.1B
| $5.84M | ﹤0.01% |
166,389
+34,387
| +26% | +$1.39M |
|
2087
CALL
Sable Offshore Corp
SOC
$773M
| $5.83M | ﹤0.01% |
646,800
+92,000
| +17% | +$869K |
|
2088
PUT
Sea Limited
SE
$75.5B
| $5.83M | ﹤0.01% |
45,700
-14,000
| -23% | -$2.07M |
|
2089
Prestige Consumer Healthcare
PBH
$2.43B
| $5.83M | ﹤0.01% |
94,490
+8,084
| +9% | +$495K |
|
2090
FTAI Aviation
FTAI
$22.2B
| $5.82M | ﹤0.01% |
29,541
-17,545
| -37% | -$2.99M |
|
2091
MannKind Corp
MNKD
$1.2B
| $5.81M | ﹤0.01% |
1,025,437
+179,381
| +21% | +$988K |
|
2092
Vontier
VNT
$4.47B
| $5.81M | ﹤0.01% |
156,260
+25,749
| +20% | +$985K |
|
|
WAY
2093
Waystar Holding Corp
WAY
$4.81B
| $5.8M | ﹤0.01% |
177,248
+16,071
| +10% | +$573K |
|
2094
Ollie's Bargain Outlet
OLLI
$4.7B
| $5.8M | ﹤0.01% |
52,948
-312,774
| -86% | -$37.7M |
|
2095
Verra Mobility
VRRM
$731M
| $5.8M | ﹤0.01% |
258,667
-140,264
| -35% | -$3.2M |
|
2096
WSFS Financial
WSFS
$4.17B
| $5.79M | ﹤0.01% |
104,758
+20,825
| +25% | +$1.14M |
|
2097
NovoCure
NVCR
$2.02B
| $5.78M | ﹤0.01% |
447,255
+49,233
| +12% | +$632K |
|
2098
Advance Auto Parts
AAP
$3.46B
| $5.78M | ﹤0.01% |
147,092
+52,503
| +56% | +$2.63M |
|
2099
CALL
Granite Construction
GVA
$5.41B
| $5.77M | ﹤0.01% |
50,000
| – | – |
|
2100
CALL
Coherent
COHR
$64B
| $5.72M | ﹤0.01% |
31,000
+6,000
| +24% | +$897K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.